MRC1 and Hyperglycemia: Hyperglycemia significantly increased the number of KCs positive for iNOS (M1 marker) post APAP treatment compared to APAP alone, but decreased the number of KCs positive for CD206 (M2 marker) (Fig. 3c–f).